INDUSTRY Pharmaceutical SERVICES Predictive and Preventative Maintenance SKILLS IBM Maximo Red Hat OpenShift Kubernetes AWS Edge Gateways IoT Sensors Situation Our client, a global pharmaceutical organization, was transitioning from a legacy, on premise system...
For life sciences leaders, the next inspection is more than a regulatory event — it is a real-time test of operational maturity. As agencies expand risk-based and digitally enabled oversight, readiness reflects whether an organization can sustain control across global...
Building a smarter maintenance model has become a strategic priority for regulated and asset-intensive organizations. Across several industries, leaders are under pressure to reduce downtime, extend asset life, safeguard quality and compliance, and make better use of...
We're proud to share that Oxford Global Resources has improved its EcoVadis Sustainability Rating for the fourth consecutive year, once again earning the EcoVadis Committed Badge in recognition of our continued efforts toward strengthening our environmental, social,...
Data center modernization has become a strategic priority as AI accelerates demand for power, cooling, and faster capacity deployment. The goal isn’t simply to add capacity, though; it is to create an environment that supports growth without introducing energy risk,...
Artificial intelligence is advancing faster than many organizations can absorb it. New tools can summarize information, generate content, automate workflows, and support complex decisions. But AI implementation and AI adoption are not the same. Implementation makes...
Drug discovery has always depended on high-stakes decisions with incomplete information, necessitating a faster, smarter model. Today, artificial intelligence is giving life sciences organizations a more powerful way to connect biological, chemical, clinical, and...
Compliance has become a defining factor in an organization's ability to transform with confidence. In regulated industries, keeping pace through manual reviews and disconnected controls is no longer enough. Compliance now sits at the center of digital reinvention,...
Rare disease clinical research is uniquely challenging, as patient populations are small and geographically dispersed, and disease courses can be highly variable. Additionally, traditional fixed trial designs often struggle to deliver timely, decision-ready evidence....
